Upper extremity and craniofacial vascularized composite allotransplantation: ethics and immunosuppression

Author:

Benedict James1,Magill Gerard1ORCID

Affiliation:

1. The Center for Healthcare Ethics, Duquesne University, 600 Forbes Avenue, Pittsburgh, Pennsylvania 15282, U.S.A.

Abstract

Vascularized composite allotransplantation (VCA) is the name most often used to refer to the transplantation of anatomical units composed of multiple tissue types (skin, bone, muscle, tendon, nerves, vessels, etc.) when such transplants do not have the primary purpose of extending life, as is the case in the more familiar field of solid organ transplantation (SOT). A serious interest in VCA developed in the late twentieth century following advances in immunosuppression which had led to significant improvements in short and medium-term survival among SOT recipients. Several ethical concerns have been raised about VCA, with many being connected in one way or another to the limitations, burdens, and risks associated with immunosuppression. This article will focus on upper extremity and craniofacial VCA, beginning with a brief review of the history of VCA including reported outcomes, followed by a discussion of the range of ethical concerns, before exploring in greater detail how immunological issues inform and shape several of the ethical concerns.

Publisher

Portland Press Ltd.

Subject

General Agricultural and Biological Sciences,General Biochemistry, Genetics and Molecular Biology

Reference77 articles.

1. Allograft vasculopathy after allogeneic vascularized knee transplantation;Transpl. Int.,2011

2. History and ethics of hand transplants;JRSM Short Rep.,2012

3. Successful hand transplantation—one-year follow-up;N. Engl. J. Med.,2000

4. Kleinert Kutz Hand Care Center Media Relations. World's Most Successful Hand Transplant Recipient Celebrates 20th Anniversary. http://handtransplant.com/ForNewsMedia/tabid/59/Default.aspx?GetStory=1754. Accessed March 26, 2019

5. Outcomes after hand and upper extremity transplantation;J. Mater. Sci. Mater. Med.,2017

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3